HEADER MEMBRANE PROTEIN 11-NOV-22 8F4V TITLE ALPHA7 NICOTINIC ACETYLCHOLINE RECEPTOR INTRACELLULAR AND TITLE 2 TRANSMEMBRANE DOMAINS BOUND TO IVERMECTIN IN A DESENSITIZED STATE COMPND MOL_ID: 1; COMPND 2 MOLECULE: NEURONAL ACETYLCHOLINE RECEPTOR SUBUNIT ALPHA-7; COMPND 3 CHAIN: A, B, C, D, E; COMPND 4 FRAGMENT: TRANSMEMBRANE DOMAIN AND INTRACELLULAR DOMAIN RESIDUES 231- COMPND 5 496; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: CHRNA7, NACHRA7; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: ROSETTA 2(DE3) PLYSS; SOURCE 9 EXPRESSION_SYSTEM_CELL: E. COLI; SOURCE 10 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 11 EXPRESSION_SYSTEM_PLASMID: PTBSG1-TMD+ICD KEYWDS NICOTINIC ACETYLCHOLINE RECEPTOR, TRANSMEMBRANE AND INTRACELLULAR KEYWDS 2 DOMAIN, DESENSITIZED STATE, IVERMECTIN, MEMBRANE PROTEIN EXPDTA SOLUTION NMR NUMMDL 15 AUTHOR V.BONDARENKO,Q.CHEN,P.TANG REVDAT 3 29-MAR-23 8F4V 1 JRNL REVDAT 2 08-MAR-23 8F4V 1 JRNL REVDAT 1 22-FEB-23 8F4V 0 JRNL AUTH V.BONDARENKO,Q.CHEN,K.SINGEWALD,N.HALOI,T.S.TILLMAN, JRNL AUTH 2 R.J.HOWARD,E.LINDAHL,Y.XU,P.TANG JRNL TITL STRUCTURAL ELUCIDATION OF IVERMECTIN BINDING TO ALPHA 7NACHR JRNL TITL 2 AND THE INDUCED CHANNEL DESENSITIZATION. JRNL REF ACS CHEM NEUROSCI V. 14 1156 2023 JRNL REFN ESSN 1948-7193 JRNL PMID 36821490 JRNL DOI 10.1021/ACSCHEMNEURO.2C00783 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : ROSETTA 3.7, MOLPROBITY REMARK 3 AUTHORS : LEAVER-FAY, TYKA, LEWIS, LANGE, THOMPSON, JACAK, REMARK 3 KAUFMAN, RENFREW, SMITH, SHEFFLER, DAVIS, COOPER, REMARK 3 TREUILLE, MANDELL, RICHTER, BAN, FLEISHMAN, CORN, REMARK 3 KIM, LYSKOV, BERRONDO, MENTZER, POPOVIC, HAVRANEK, REMARK 3 KARANICOLAS, DAS, MEILER, KORTEMME, GRAY, KUHLMAN, REMARK 3 BAKER, AND BRADLEY (ROSETTA), RICHARDSON REMARK 3 (MOLPROBITY) REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 8F4V COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 14-NOV-22. REMARK 100 THE DEPOSITION ID IS D_1000269944. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 318 REMARK 210 PH : 4.7 REMARK 210 IONIC STRENGTH : 25 REMARK 210 PRESSURE : 1 ATM REMARK 210 SAMPLE CONTENTS : 0.25 MM [U-15N] ALPHA7NACHR C317 REMARK 210 TMD+ICD, 5 MM SODIUM ACETATE, 35 REMARK 210 MM LDAO, 25 MM SODIUM CHLORIDE, REMARK 210 5 % D2O, 20 UM DSS, 95% H2O/5% REMARK 210 D2O; 0.25 MM [U-15N] ALPHA7NACHR REMARK 210 C317 TMD+ICD, 5 MM SODIUM REMARK 210 ACETATE, 35 MM LDAO, 25 MM REMARK 210 SODIUM CHLORIDE, 5 % D2O, 20 UM REMARK 210 DSS, 30 UM IVERMECTIN, 0.1 % REMARK 210 DMSO, 95% H2O/5% D2O; 0.25 MM [U- REMARK 210 15N] ALPHA7NACHR C317 TMD+ICD, 5 REMARK 210 MM SODIUM ACETATE, 35 MM LDAO, REMARK 210 25 MM SODIUM CHLORIDE, 5 % D2O, REMARK 210 20 UM DSS, 100 UM IVERMECTIN, REMARK 210 0.3 % DMSO, 95% H2O/5% D2O; 0.25 REMARK 210 MM [U-15N] ALPHA7NACHR C317 TMD+ REMARK 210 ICD, 5 MM SODIUM ACETATE, 35 MM REMARK 210 LDAO, 25 MM SODIUM CHLORIDE, 5 % REMARK 210 D2O, 20 UM DSS, 250 UM REMARK 210 IVERMECTIN, 0.55 % DMSO, 95% H2O/ REMARK 210 5% D2O; 0.25 MM [U-15N] REMARK 210 ALPHA7NACHR C317 TMD+ICD, 5 MM REMARK 210 SODIUM ACETATE, 35 MM LDAO, 25 REMARK 210 MM SODIUM CHLORIDE, 5 % D2O, 20 REMARK 210 UM DSS, 500 UM IVERMECTIN, 0.95 % REMARK 210 DMSO, 95% H2O/5% D2O; 0.25 MM REMARK 210 [U-15N] ALPHA7NACHR C317 TMD+ICD, REMARK 210 5 MM SODIUM ACETATE, 35 MM LDAO, REMARK 210 25 MM SODIUM CHLORIDE, 5 % D2O, REMARK 210 20 UM DSS, 500 UM IVERMECTIN, REMARK 210 0.8 % DMSO, 95% H2O/5% D2O; 0.25 REMARK 210 MM [U-15N] ALPHA7NACHR C317 TMD+ REMARK 210 ICD, 5 MM SODIUM ACETATE, 35 MM REMARK 210 LDAO, 25 MM SODIUM CHLORIDE, 5 % REMARK 210 D2O, 20 UM DSS, 500 UM REMARK 210 IVERMECTIN, 0.8 % DMSO, 95% H2O/ REMARK 210 5% D2O; 0.25 MM [U-15N] REMARK 210 ALPHA7NACHR C317 TMD+ICD, 5 MM REMARK 210 SODIUM ACETATE, 35 MM LDAO, 25 REMARK 210 MM SODIUM CHLORIDE, 5 % D2O, 20 REMARK 210 UM DSS, 500 UM IVERMECTIN, 0.8 % REMARK 210 DMSO, 95% H2O/5% D2O; 0.20 MM [U- REMARK 210 15N] ALPHA7NACHR C317 TMD+ICD, 5 REMARK 210 MM SODIUM ACETATE, 35 MM LDAO, REMARK 210 25 MM SODIUM CHLORIDE, 5 % D2O, REMARK 210 20 UM DSS, 500 UM IVERMECTIN, REMARK 210 0.8 % DMSO, 95% H2O/5% D2O; 0.22 REMARK 210 MM [U-15N] V311C-MTSL REMARK 210 ALPHA7NACHR TMD+ICD, 5 MM SODIUM REMARK 210 ACETATE, 35 MM LDAO, 25 MM REMARK 210 SODIUM CHLORIDE, 5 % D2O, 20 UM REMARK 210 DSS, 220 UM IVERMECTIN, 0.4 % REMARK 210 DMSO, 95% H2O/5% D2O; 0.22 MM [U- REMARK 210 15N] V311C-MTSL ALPHA7NACHR TMD+ REMARK 210 ICD, 5 MM SODIUM ACETATE, 35 MM REMARK 210 LDAO, 25 MM SODIUM CHLORIDE, 5 % REMARK 210 D2O, 20 UM DSS, 95% H2O/5% D2O; REMARK 210 0.22 MM [U-15N] C335-MTSL REMARK 210 ALPHA7NACHR TMD+ICD, 5 MM SODIUM REMARK 210 ACETATE, 26 MM LDAO, 25 MM REMARK 210 SODIUM CHLORIDE, 5 % D2O, 20 UM REMARK 210 DSS, 220 UM IVERMECTIN, 0.4 % REMARK 210 DMSO, 95% H2O/5% D2O; 0.22 MM [U- REMARK 210 15N] C335-MTSL ALPHA7NACHR TMD+ REMARK 210 ICD, 5 MM SODIUM ACETATE, 26 MM REMARK 210 LDAO, 25 MM SODIUM CHLORIDE, 5 % REMARK 210 D2O, 20 UM DSS, 95% H2O/5% D2O; REMARK 210 0.2 MM [U-15N] C342-MTSL REMARK 210 ALPHA7NACHR TMD+ICD, 5 MM SODIUM REMARK 210 ACETATE, 26 MM LDAO, 25 MM REMARK 210 SODIUM CHLORIDE, 5 % D2O, 20 UM REMARK 210 DSS, 200 UM IVERMECTIN, 0.4 % REMARK 210 DMSO, 95% H2O/5% D2O; 0.2 % [U- REMARK 210 15N] C342-MTSL ALPHA7NACHR TMD+ REMARK 210 ICD, 5 MM SODIUM ACETATE, 26 MM REMARK 210 LDAO, 25 MM SODIUM CHLORIDE, 5 % REMARK 210 D2O, 20 UM DSS, 95% H2O/5% D2O; REMARK 210 0.2 MM [U-15N] S350C-MTSL REMARK 210 ALPHA7NACHR TMD+ICD, 5 MM SODIUM REMARK 210 ACETATE, 44 MM LDAO, 25 MM REMARK 210 SODIUM CHLORIDE, 5 % D2O, 20 UM REMARK 210 DSS, 200 UM IVERMECTIN, 0.4 % REMARK 210 DMSO, 95% H2O/5% D2O; 0.2 MM [U- REMARK 210 15N] S350C-MTSL ALPHA7NACHR TMD+ REMARK 210 ICD, 5 MM SODIUM ACETATE, 44 MM REMARK 210 LDAO, 25 MM SODIUM CHLORIDE, 5 % REMARK 210 D2O, 20 UM DSS, 95% H2O/5% D2O; REMARK 210 0.2 MM [U-15N] C375-MTSL REMARK 210 ALPHA7NACHR TMD+ICD, 5 MM SODIUM REMARK 210 ACETATE, 35 MM LDAO, 25 MM REMARK 210 SODIUM CHLORIDE, 5 % D2O, 20 UM REMARK 210 DSS, 200 UM IVERMECTIN, 0.4 % REMARK 210 DMSO, 95% H2O/5% D2O; 0.2 MM [U- REMARK 210 15N] C375-MTSL ALPHA7NACHR TMD+ REMARK 210 ICD, 5 MM SODIUM ACETATE, 35 MM REMARK 210 LDAO, 25 MM SODIUM CHLORIDE, 5 % REMARK 210 D2O, 20 UM DSS, 95% H2O/5% D2O; REMARK 210 0.25 MM [U-15N] C390-MTSL REMARK 210 ALPHA7NACHR TMD+ICD, 5 MM SODIUM REMARK 210 ACETATE, 44 MM LDAO, 25 MM REMARK 210 SODIUM CHLORIDE, 5 % D2O, 20 UM REMARK 210 DSS, 250 UM IVERMECTIN, 0.4 % REMARK 210 DMSO, 95% H2O/5% D2O; 0.25 MM [U- REMARK 210 15N] C390-MTSL ALPHA7NACHR TMD+ REMARK 210 ICD, 5 MM SODIUM ACETATE, 44 MM REMARK 210 LDAO, 25 MM SODIUM CHLORIDE, 5 % REMARK 210 D2O, 20 UM DSS, 95% H2O/5% D2O; REMARK 210 0.24 MM [U-15N] L415C-MTSL REMARK 210 ALPHA7NACHR TMD+ICD, 5 MM SODIUM REMARK 210 ACETATE, 35 MM LDAO, 25 MM REMARK 210 SODIUM CHLORIDE, 5 % D2O, 20 UM REMARK 210 DSS, 240 UM IVERMECTIN, 0.4 % REMARK 210 DMSO, 95% H2O/5% D2O; 0.24 MM [U- REMARK 210 15N] L415C-MTSL ALPHA7NACHR TMD+ REMARK 210 ICD, 5 MM SODIUM ACETATE, 35 MM REMARK 210 LDAO, 25 MM SODIUM CHLORIDE, 5 % REMARK 210 D2O, 20 UM DSS, 95% H2O/5% D2O; REMARK 210 0.2 MM [U-15N] C435-MTSL REMARK 210 ALPHA7NACHR TMD+ICD, 5 MM SODIUM REMARK 210 ACETATE, 22 MM LDAO, 25 MM REMARK 210 SODIUM CHLORIDE, 5 % D2O, 20 UM REMARK 210 DSS, 200 UM IVERMECTIN, 0.4 % REMARK 210 DMSO, 95% H2O/5% D2O; 0.2 MM [U- REMARK 210 15N] C435-MTSL ALPHA7NACHR TMD+ REMARK 210 ICD, 5 MM SODIUM ACETATE, 22 MM REMARK 210 LDAO, 25 MM SODIUM CHLORIDE, 5 % REMARK 210 D2O, 20 UM DSS, 95% H2O/5% D2O; REMARK 210 0.22 MM [U-13C; U-15N] REMARK 210 ALPHA7NACHR C317 TMD+ICD, 5 MM REMARK 210 SODIUM ACETATE, 44 MM LDAO, 25 REMARK 210 MM SODIUM CHLORIDE, 5 % D2O, 20 REMARK 210 UM DSS, 30 UM IVERMECTIN, 30 UM REMARK 210 PNU, 0.2 % DMSO, 95% H2O/5% D2O; REMARK 210 0.22 MM [U-13C; U-15N] REMARK 210 ALPHA7NACHR C317 TMD+ICD, 5 MM REMARK 210 SODIUM ACETATE, 44 MM LDAO, 25 REMARK 210 MM SODIUM CHLORIDE, 5 % D2O, 20 REMARK 210 UM DSS, 95% H2O/5% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D 1H-15N TROSY-HSQC; 2D 1H-15N REMARK 210 STD TROSY-HSQC; 2D NOESY; 3D REMARK 210 TROSY-HNCO REMARK 210 SPECTROMETER FIELD STRENGTH : 800 MHZ REMARK 210 SPECTROMETER MODEL : AVANCE II REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : TOPSPIN 3.2, NMRPIPE 10.9, REMARK 210 SPARKY 3.190, NMRFAM-SPARKY REMARK 210 1.470, CS-ROSETTA 3.17, ROSETTA REMARK 210 3.7 REMARK 210 METHOD USED : NA REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 1000 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 15 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH THE LOWEST REMARK 210 ENERGY REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: PENTAMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D, E REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 465 SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 MODELS 1-15 REMARK 465 RES C SSSEQI REMARK 465 SER A 203 REMARK 465 ASN A 204 REMARK 465 ALA A 205 REMARK 465 GLU A 206 REMARK 465 GLU A 207 REMARK 465 GLU A 208 REMARK 465 GLU A 473 REMARK 465 GLU A 474 REMARK 465 SER B 203 REMARK 465 ASN B 204 REMARK 465 ALA B 205 REMARK 465 GLU B 206 REMARK 465 GLU B 207 REMARK 465 GLU B 208 REMARK 465 GLU B 473 REMARK 465 GLU B 474 REMARK 465 SER C 203 REMARK 465 ASN C 204 REMARK 465 ALA C 205 REMARK 465 GLU C 206 REMARK 465 GLU C 207 REMARK 465 GLU C 208 REMARK 465 GLU C 473 REMARK 465 GLU C 474 REMARK 465 SER D 203 REMARK 465 ASN D 204 REMARK 465 ALA D 205 REMARK 465 GLU D 206 REMARK 465 GLU D 207 REMARK 465 GLU D 208 REMARK 465 GLU D 473 REMARK 465 GLU D 474 REMARK 465 SER E 203 REMARK 465 ASN E 204 REMARK 465 ALA E 205 REMARK 465 GLU E 206 REMARK 465 GLU E 207 REMARK 465 GLU E 208 REMARK 465 GLU E 473 REMARK 465 GLU E 474 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 2 LEU A 231 34.67 -99.85 REMARK 500 2 ARG A 368 58.50 -94.11 REMARK 500 2 PRO A 377 45.39 -82.40 REMARK 500 2 PRO A 405 48.75 -80.03 REMARK 500 2 LEU B 231 32.30 -98.61 REMARK 500 2 ARG B 368 58.58 -94.33 REMARK 500 2 PRO B 377 45.63 -82.96 REMARK 500 2 PRO B 405 48.68 -79.81 REMARK 500 2 LEU C 231 32.59 -98.35 REMARK 500 2 ARG C 368 57.28 -92.93 REMARK 500 2 PRO C 377 46.02 -82.82 REMARK 500 2 PRO C 405 48.24 -81.00 REMARK 500 2 LEU D 231 32.22 -98.62 REMARK 500 2 ARG D 368 58.96 -95.15 REMARK 500 2 PRO D 377 45.92 -81.66 REMARK 500 2 PRO D 405 48.62 -80.55 REMARK 500 2 LEU E 231 32.38 -98.25 REMARK 500 2 ARG E 368 58.98 -94.25 REMARK 500 2 PRO E 377 49.57 -81.43 REMARK 500 2 ASP E 380 149.14 -170.17 REMARK 500 2 PRO E 405 48.53 -80.75 REMARK 500 3 HIS A 337 -168.66 -78.88 REMARK 500 3 VAL A 373 -52.94 -122.98 REMARK 500 3 VAL A 383 -60.42 -102.24 REMARK 500 3 HIS A 397 56.04 -92.11 REMARK 500 3 HIS B 337 -168.91 -78.70 REMARK 500 3 VAL B 373 -52.86 -122.81 REMARK 500 3 VAL B 383 -60.60 -100.62 REMARK 500 3 HIS B 397 56.05 -92.02 REMARK 500 3 HIS C 337 -168.50 -78.38 REMARK 500 3 VAL C 373 -52.93 -122.59 REMARK 500 3 VAL C 383 -60.57 -102.36 REMARK 500 3 HIS C 397 56.01 -91.81 REMARK 500 3 HIS D 337 -168.63 -78.72 REMARK 500 3 VAL D 373 -52.96 -123.12 REMARK 500 3 VAL D 383 -60.66 -102.63 REMARK 500 3 HIS D 397 55.91 -92.08 REMARK 500 3 HIS E 337 -168.67 -78.76 REMARK 500 3 VAL E 373 -53.05 -123.01 REMARK 500 3 VAL E 383 -60.44 -100.64 REMARK 500 3 HIS E 397 55.96 -92.09 REMARK 500 4 HIS A 337 -168.25 -79.30 REMARK 500 4 VAL A 373 -53.16 -122.86 REMARK 500 4 PRO A 377 72.87 -69.11 REMARK 500 4 HIS B 337 -168.17 -79.38 REMARK 500 4 VAL B 373 -53.06 -122.82 REMARK 500 4 HIS C 337 -167.93 -79.48 REMARK 500 4 VAL C 373 -53.09 -122.86 REMARK 500 4 PRO C 377 72.65 -69.17 REMARK 500 4 HIS D 337 -168.11 -79.44 REMARK 500 REMARK 500 THIS ENTRY HAS 149 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 31058 RELATED DB: BMRB REMARK 900 ALPHA7 NICOTINIC ACETYLCHOLINE RECEPTOR INTRACELLULAR AND REMARK 900 TRANSMEMBRANE DOMAINS BOUND TO IVERMECTIN IN A DESENSITIZED STATE DBREF 8F4V A 209 474 UNP P36544 ACHA7_HUMAN 231 496 DBREF 8F4V B 209 474 UNP P36544 ACHA7_HUMAN 231 496 DBREF 8F4V C 209 474 UNP P36544 ACHA7_HUMAN 231 496 DBREF 8F4V D 209 474 UNP P36544 ACHA7_HUMAN 231 496 DBREF 8F4V E 209 474 UNP P36544 ACHA7_HUMAN 231 496 SEQADV 8F4V SER A 203 UNP P36544 EXPRESSION TAG SEQADV 8F4V ASN A 204 UNP P36544 EXPRESSION TAG SEQADV 8F4V ALA A 205 UNP P36544 EXPRESSION TAG SEQADV 8F4V GLU A 206 UNP P36544 EXPRESSION TAG SEQADV 8F4V GLU A 207 UNP P36544 EXPRESSION TAG SEQADV 8F4V GLU A 208 UNP P36544 EXPRESSION TAG SEQADV 8F4V SER A 263 UNP P36544 ALA 285 ENGINEERED MUTATION SEQADV 8F4V SER A 268 UNP P36544 VAL 290 ENGINEERED MUTATION SEQADV 8F4V SER A 270 UNP P36544 LEU 292 ENGINEERED MUTATION SEQADV 8F4V GLU A 474 UNP P36544 ALA 496 ENGINEERED MUTATION SEQADV 8F4V SER B 203 UNP P36544 EXPRESSION TAG SEQADV 8F4V ASN B 204 UNP P36544 EXPRESSION TAG SEQADV 8F4V ALA B 205 UNP P36544 EXPRESSION TAG SEQADV 8F4V GLU B 206 UNP P36544 EXPRESSION TAG SEQADV 8F4V GLU B 207 UNP P36544 EXPRESSION TAG SEQADV 8F4V GLU B 208 UNP P36544 EXPRESSION TAG SEQADV 8F4V SER B 263 UNP P36544 ALA 285 ENGINEERED MUTATION SEQADV 8F4V SER B 268 UNP P36544 VAL 290 ENGINEERED MUTATION SEQADV 8F4V SER B 270 UNP P36544 LEU 292 ENGINEERED MUTATION SEQADV 8F4V GLU B 474 UNP P36544 ALA 496 ENGINEERED MUTATION SEQADV 8F4V SER C 203 UNP P36544 EXPRESSION TAG SEQADV 8F4V ASN C 204 UNP P36544 EXPRESSION TAG SEQADV 8F4V ALA C 205 UNP P36544 EXPRESSION TAG SEQADV 8F4V GLU C 206 UNP P36544 EXPRESSION TAG SEQADV 8F4V GLU C 207 UNP P36544 EXPRESSION TAG SEQADV 8F4V GLU C 208 UNP P36544 EXPRESSION TAG SEQADV 8F4V SER C 263 UNP P36544 ALA 285 ENGINEERED MUTATION SEQADV 8F4V SER C 268 UNP P36544 VAL 290 ENGINEERED MUTATION SEQADV 8F4V SER C 270 UNP P36544 LEU 292 ENGINEERED MUTATION SEQADV 8F4V GLU C 474 UNP P36544 ALA 496 ENGINEERED MUTATION SEQADV 8F4V SER D 203 UNP P36544 EXPRESSION TAG SEQADV 8F4V ASN D 204 UNP P36544 EXPRESSION TAG SEQADV 8F4V ALA D 205 UNP P36544 EXPRESSION TAG SEQADV 8F4V GLU D 206 UNP P36544 EXPRESSION TAG SEQADV 8F4V GLU D 207 UNP P36544 EXPRESSION TAG SEQADV 8F4V GLU D 208 UNP P36544 EXPRESSION TAG SEQADV 8F4V SER D 263 UNP P36544 ALA 285 ENGINEERED MUTATION SEQADV 8F4V SER D 268 UNP P36544 VAL 290 ENGINEERED MUTATION SEQADV 8F4V SER D 270 UNP P36544 LEU 292 ENGINEERED MUTATION SEQADV 8F4V GLU D 474 UNP P36544 ALA 496 ENGINEERED MUTATION SEQADV 8F4V SER E 203 UNP P36544 EXPRESSION TAG SEQADV 8F4V ASN E 204 UNP P36544 EXPRESSION TAG SEQADV 8F4V ALA E 205 UNP P36544 EXPRESSION TAG SEQADV 8F4V GLU E 206 UNP P36544 EXPRESSION TAG SEQADV 8F4V GLU E 207 UNP P36544 EXPRESSION TAG SEQADV 8F4V GLU E 208 UNP P36544 EXPRESSION TAG SEQADV 8F4V SER E 263 UNP P36544 ALA 285 ENGINEERED MUTATION SEQADV 8F4V SER E 268 UNP P36544 VAL 290 ENGINEERED MUTATION SEQADV 8F4V SER E 270 UNP P36544 LEU 292 ENGINEERED MUTATION SEQADV 8F4V GLU E 474 UNP P36544 ALA 496 ENGINEERED MUTATION SEQRES 1 A 272 SER ASN ALA GLU GLU GLU LEU TYR TYR GLY LEU ASN LEU SEQRES 2 A 272 LEU ILE PRO CYS VAL LEU ILE SER ALA LEU ALA LEU LEU SEQRES 3 A 272 VAL PHE LEU LEU PRO ALA ASP SER GLY GLU LYS ILE SER SEQRES 4 A 272 LEU GLY ILE THR VAL LEU LEU SER LEU THR VAL PHE MET SEQRES 5 A 272 LEU LEU VAL ALA GLU ILE MET PRO SER THR SER ASP SER SEQRES 6 A 272 SER PRO SER ILE ALA GLN TYR PHE ALA SER THR MET ILE SEQRES 7 A 272 ILE VAL GLY LEU SER VAL VAL VAL THR VAL ILE VAL LEU SEQRES 8 A 272 GLN TYR HIS HIS HIS ASP PRO ASP GLY GLY LYS MET PRO SEQRES 9 A 272 LYS TRP THR ARG VAL ILE LEU LEU ASN TRP CYS ALA TRP SEQRES 10 A 272 PHE LEU ARG MET LYS ARG PRO GLY GLU ASP LYS VAL ARG SEQRES 11 A 272 PRO ALA CYS GLN HIS LYS GLN ARG ARG CYS SER LEU ALA SEQRES 12 A 272 SER VAL GLU MET SER ALA VAL ALA PRO PRO PRO ALA SER SEQRES 13 A 272 ASN GLY ASN LEU LEU TYR ILE GLY PHE ARG GLY LEU ASP SEQRES 14 A 272 GLY VAL HIS CYS VAL PRO THR PRO ASP SER GLY VAL VAL SEQRES 15 A 272 CYS GLY ARG MET ALA CYS SER PRO THR HIS ASP GLU HIS SEQRES 16 A 272 LEU LEU HIS GLY GLY GLN PRO PRO GLU GLY ASP PRO ASP SEQRES 17 A 272 LEU ALA LYS ILE LEU GLU GLU VAL ARG TYR ILE ALA ASN SEQRES 18 A 272 ARG PHE ARG CYS GLN ASP GLU SER GLU ALA VAL CYS SER SEQRES 19 A 272 GLU TRP LYS PHE ALA ALA CYS VAL VAL ASP ARG LEU CYS SEQRES 20 A 272 LEU MET ALA PHE SER VAL PHE THR ILE ILE CYS THR ILE SEQRES 21 A 272 GLY ILE LEU MET SER ALA PRO ASN PHE VAL GLU GLU SEQRES 1 B 272 SER ASN ALA GLU GLU GLU LEU TYR TYR GLY LEU ASN LEU SEQRES 2 B 272 LEU ILE PRO CYS VAL LEU ILE SER ALA LEU ALA LEU LEU SEQRES 3 B 272 VAL PHE LEU LEU PRO ALA ASP SER GLY GLU LYS ILE SER SEQRES 4 B 272 LEU GLY ILE THR VAL LEU LEU SER LEU THR VAL PHE MET SEQRES 5 B 272 LEU LEU VAL ALA GLU ILE MET PRO SER THR SER ASP SER SEQRES 6 B 272 SER PRO SER ILE ALA GLN TYR PHE ALA SER THR MET ILE SEQRES 7 B 272 ILE VAL GLY LEU SER VAL VAL VAL THR VAL ILE VAL LEU SEQRES 8 B 272 GLN TYR HIS HIS HIS ASP PRO ASP GLY GLY LYS MET PRO SEQRES 9 B 272 LYS TRP THR ARG VAL ILE LEU LEU ASN TRP CYS ALA TRP SEQRES 10 B 272 PHE LEU ARG MET LYS ARG PRO GLY GLU ASP LYS VAL ARG SEQRES 11 B 272 PRO ALA CYS GLN HIS LYS GLN ARG ARG CYS SER LEU ALA SEQRES 12 B 272 SER VAL GLU MET SER ALA VAL ALA PRO PRO PRO ALA SER SEQRES 13 B 272 ASN GLY ASN LEU LEU TYR ILE GLY PHE ARG GLY LEU ASP SEQRES 14 B 272 GLY VAL HIS CYS VAL PRO THR PRO ASP SER GLY VAL VAL SEQRES 15 B 272 CYS GLY ARG MET ALA CYS SER PRO THR HIS ASP GLU HIS SEQRES 16 B 272 LEU LEU HIS GLY GLY GLN PRO PRO GLU GLY ASP PRO ASP SEQRES 17 B 272 LEU ALA LYS ILE LEU GLU GLU VAL ARG TYR ILE ALA ASN SEQRES 18 B 272 ARG PHE ARG CYS GLN ASP GLU SER GLU ALA VAL CYS SER SEQRES 19 B 272 GLU TRP LYS PHE ALA ALA CYS VAL VAL ASP ARG LEU CYS SEQRES 20 B 272 LEU MET ALA PHE SER VAL PHE THR ILE ILE CYS THR ILE SEQRES 21 B 272 GLY ILE LEU MET SER ALA PRO ASN PHE VAL GLU GLU SEQRES 1 C 272 SER ASN ALA GLU GLU GLU LEU TYR TYR GLY LEU ASN LEU SEQRES 2 C 272 LEU ILE PRO CYS VAL LEU ILE SER ALA LEU ALA LEU LEU SEQRES 3 C 272 VAL PHE LEU LEU PRO ALA ASP SER GLY GLU LYS ILE SER SEQRES 4 C 272 LEU GLY ILE THR VAL LEU LEU SER LEU THR VAL PHE MET SEQRES 5 C 272 LEU LEU VAL ALA GLU ILE MET PRO SER THR SER ASP SER SEQRES 6 C 272 SER PRO SER ILE ALA GLN TYR PHE ALA SER THR MET ILE SEQRES 7 C 272 ILE VAL GLY LEU SER VAL VAL VAL THR VAL ILE VAL LEU SEQRES 8 C 272 GLN TYR HIS HIS HIS ASP PRO ASP GLY GLY LYS MET PRO SEQRES 9 C 272 LYS TRP THR ARG VAL ILE LEU LEU ASN TRP CYS ALA TRP SEQRES 10 C 272 PHE LEU ARG MET LYS ARG PRO GLY GLU ASP LYS VAL ARG SEQRES 11 C 272 PRO ALA CYS GLN HIS LYS GLN ARG ARG CYS SER LEU ALA SEQRES 12 C 272 SER VAL GLU MET SER ALA VAL ALA PRO PRO PRO ALA SER SEQRES 13 C 272 ASN GLY ASN LEU LEU TYR ILE GLY PHE ARG GLY LEU ASP SEQRES 14 C 272 GLY VAL HIS CYS VAL PRO THR PRO ASP SER GLY VAL VAL SEQRES 15 C 272 CYS GLY ARG MET ALA CYS SER PRO THR HIS ASP GLU HIS SEQRES 16 C 272 LEU LEU HIS GLY GLY GLN PRO PRO GLU GLY ASP PRO ASP SEQRES 17 C 272 LEU ALA LYS ILE LEU GLU GLU VAL ARG TYR ILE ALA ASN SEQRES 18 C 272 ARG PHE ARG CYS GLN ASP GLU SER GLU ALA VAL CYS SER SEQRES 19 C 272 GLU TRP LYS PHE ALA ALA CYS VAL VAL ASP ARG LEU CYS SEQRES 20 C 272 LEU MET ALA PHE SER VAL PHE THR ILE ILE CYS THR ILE SEQRES 21 C 272 GLY ILE LEU MET SER ALA PRO ASN PHE VAL GLU GLU SEQRES 1 D 272 SER ASN ALA GLU GLU GLU LEU TYR TYR GLY LEU ASN LEU SEQRES 2 D 272 LEU ILE PRO CYS VAL LEU ILE SER ALA LEU ALA LEU LEU SEQRES 3 D 272 VAL PHE LEU LEU PRO ALA ASP SER GLY GLU LYS ILE SER SEQRES 4 D 272 LEU GLY ILE THR VAL LEU LEU SER LEU THR VAL PHE MET SEQRES 5 D 272 LEU LEU VAL ALA GLU ILE MET PRO SER THR SER ASP SER SEQRES 6 D 272 SER PRO SER ILE ALA GLN TYR PHE ALA SER THR MET ILE SEQRES 7 D 272 ILE VAL GLY LEU SER VAL VAL VAL THR VAL ILE VAL LEU SEQRES 8 D 272 GLN TYR HIS HIS HIS ASP PRO ASP GLY GLY LYS MET PRO SEQRES 9 D 272 LYS TRP THR ARG VAL ILE LEU LEU ASN TRP CYS ALA TRP SEQRES 10 D 272 PHE LEU ARG MET LYS ARG PRO GLY GLU ASP LYS VAL ARG SEQRES 11 D 272 PRO ALA CYS GLN HIS LYS GLN ARG ARG CYS SER LEU ALA SEQRES 12 D 272 SER VAL GLU MET SER ALA VAL ALA PRO PRO PRO ALA SER SEQRES 13 D 272 ASN GLY ASN LEU LEU TYR ILE GLY PHE ARG GLY LEU ASP SEQRES 14 D 272 GLY VAL HIS CYS VAL PRO THR PRO ASP SER GLY VAL VAL SEQRES 15 D 272 CYS GLY ARG MET ALA CYS SER PRO THR HIS ASP GLU HIS SEQRES 16 D 272 LEU LEU HIS GLY GLY GLN PRO PRO GLU GLY ASP PRO ASP SEQRES 17 D 272 LEU ALA LYS ILE LEU GLU GLU VAL ARG TYR ILE ALA ASN SEQRES 18 D 272 ARG PHE ARG CYS GLN ASP GLU SER GLU ALA VAL CYS SER SEQRES 19 D 272 GLU TRP LYS PHE ALA ALA CYS VAL VAL ASP ARG LEU CYS SEQRES 20 D 272 LEU MET ALA PHE SER VAL PHE THR ILE ILE CYS THR ILE SEQRES 21 D 272 GLY ILE LEU MET SER ALA PRO ASN PHE VAL GLU GLU SEQRES 1 E 272 SER ASN ALA GLU GLU GLU LEU TYR TYR GLY LEU ASN LEU SEQRES 2 E 272 LEU ILE PRO CYS VAL LEU ILE SER ALA LEU ALA LEU LEU SEQRES 3 E 272 VAL PHE LEU LEU PRO ALA ASP SER GLY GLU LYS ILE SER SEQRES 4 E 272 LEU GLY ILE THR VAL LEU LEU SER LEU THR VAL PHE MET SEQRES 5 E 272 LEU LEU VAL ALA GLU ILE MET PRO SER THR SER ASP SER SEQRES 6 E 272 SER PRO SER ILE ALA GLN TYR PHE ALA SER THR MET ILE SEQRES 7 E 272 ILE VAL GLY LEU SER VAL VAL VAL THR VAL ILE VAL LEU SEQRES 8 E 272 GLN TYR HIS HIS HIS ASP PRO ASP GLY GLY LYS MET PRO SEQRES 9 E 272 LYS TRP THR ARG VAL ILE LEU LEU ASN TRP CYS ALA TRP SEQRES 10 E 272 PHE LEU ARG MET LYS ARG PRO GLY GLU ASP LYS VAL ARG SEQRES 11 E 272 PRO ALA CYS GLN HIS LYS GLN ARG ARG CYS SER LEU ALA SEQRES 12 E 272 SER VAL GLU MET SER ALA VAL ALA PRO PRO PRO ALA SER SEQRES 13 E 272 ASN GLY ASN LEU LEU TYR ILE GLY PHE ARG GLY LEU ASP SEQRES 14 E 272 GLY VAL HIS CYS VAL PRO THR PRO ASP SER GLY VAL VAL SEQRES 15 E 272 CYS GLY ARG MET ALA CYS SER PRO THR HIS ASP GLU HIS SEQRES 16 E 272 LEU LEU HIS GLY GLY GLN PRO PRO GLU GLY ASP PRO ASP SEQRES 17 E 272 LEU ALA LYS ILE LEU GLU GLU VAL ARG TYR ILE ALA ASN SEQRES 18 E 272 ARG PHE ARG CYS GLN ASP GLU SER GLU ALA VAL CYS SER SEQRES 19 E 272 GLU TRP LYS PHE ALA ALA CYS VAL VAL ASP ARG LEU CYS SEQRES 20 E 272 LEU MET ALA PHE SER VAL PHE THR ILE ILE CYS THR ILE SEQRES 21 E 272 GLY ILE LEU MET SER ALA PRO ASN PHE VAL GLU GLU HET IVM A 501 136 HET IVM A 502 136 HET IVM B 501 136 HET IVM C 501 136 HET IVM D 501 136 HETNAM IVM (2AE,4E,5'S,6S,6'R,7S,8E,11R,13R,15S,17AR,20R,20AR, HETNAM 2 IVM 20BS)-6'-[(2S)-BUTAN-2-YL]-20,20B-DIHYDROXY-5',6,8,19- HETNAM 3 IVM TETRAMETHYL-17 -OXO-3',4',5',6,6',10,11,14,15,17,17A, HETNAM 4 IVM 20,20A,20B-TETRADECAHYDRO-2H,7H-SPIRO[11,15- HETNAM 5 IVM METHANOFURO[4,3,2-PQ][2,6]BENZODIOXACY CLOOCTADECINE- HETNAM 6 IVM 13,2'-PYRAN]-7-YL 2,6-DIDEOXY-4-O-(2,6-DIDEOXY-3-O- HETNAM 7 IVM METHYL-ALPHA-L-ARABINO-HEXOPYRANOSYL)-3-O-METHYL- HETNAM 8 IVM ALPHA-L-ARABINO-HEXOPYRANOSIDE HETSYN IVM 22,23-DIHYDROAVERMECTIN B1A; IVERMECTIN FORMUL 6 IVM 5(C48 H74 O14) HELIX 1 AA1 LEU A 215 ALA A 226 1 12 HELIX 2 AA2 LEU A 227 LEU A 232 5 6 HELIX 3 AA3 GLU A 238 MET A 261 1 24 HELIX 4 AA4 PRO A 269 HIS A 298 1 30 HELIX 5 AA5 LYS A 307 TRP A 319 1 13 HELIX 6 AA6 ARG A 325 LYS A 330 1 6 HELIX 7 AA7 HIS A 337 ARG A 341 5 5 HELIX 8 AA8 GLY A 360 PHE A 367 1 8 HELIX 9 AA9 PRO A 409 VAL A 472 1 64 HELIX 10 AB1 LEU B 215 PHE B 230 1 16 HELIX 11 AB2 GLU B 238 MET B 261 1 24 HELIX 12 AB3 SER B 270 HIS B 298 1 29 HELIX 13 AB4 LYS B 307 TRP B 319 1 13 HELIX 14 AB5 ARG B 325 LYS B 330 1 6 HELIX 15 AB6 HIS B 337 ARG B 341 5 5 HELIX 16 AB7 GLY B 360 PHE B 367 1 8 HELIX 17 AB8 ASP B 408 VAL B 472 1 65 HELIX 18 AB9 LEU C 215 LEU C 228 1 14 HELIX 19 AC1 VAL C 229 LEU C 232 5 4 HELIX 20 AC2 GLU C 238 MET C 261 1 24 HELIX 21 AC3 PRO C 269 HIS C 298 1 30 HELIX 22 AC4 LYS C 307 TRP C 319 1 13 HELIX 23 AC5 ARG C 325 LYS C 330 1 6 HELIX 24 AC6 HIS C 337 ARG C 341 5 5 HELIX 25 AC7 GLY C 360 PHE C 367 1 8 HELIX 26 AC8 ASP C 408 VAL C 472 1 65 HELIX 27 AC9 LEU D 215 PHE D 230 1 16 HELIX 28 AD1 GLU D 238 MET D 261 1 24 HELIX 29 AD2 PRO D 269 HIS D 298 1 30 HELIX 30 AD3 LYS D 307 TRP D 319 1 13 HELIX 31 AD4 ARG D 325 LYS D 330 1 6 HELIX 32 AD5 HIS D 337 ARG D 341 5 5 HELIX 33 AD6 GLY D 360 PHE D 367 1 8 HELIX 34 AD7 ASP D 408 VAL D 472 1 65 HELIX 35 AD8 TYR E 210 LEU E 215 1 6 HELIX 36 AD9 LEU E 216 PHE E 230 1 15 HELIX 37 AE1 GLU E 238 MET E 261 1 24 HELIX 38 AE2 SER E 270 HIS E 298 1 29 HELIX 39 AE3 LYS E 307 TRP E 319 1 13 HELIX 40 AE4 ARG E 325 LYS E 330 1 6 HELIX 41 AE5 HIS E 337 ARG E 341 5 5 HELIX 42 AE6 GLY E 360 PHE E 367 1 8 HELIX 43 AE7 PRO E 409 VAL E 472 1 64 CISPEP 1 MET A 305 PRO A 306 2 -1.28 CISPEP 2 MET B 305 PRO B 306 2 -1.29 CISPEP 3 MET C 305 PRO C 306 2 -1.39 CISPEP 4 MET D 305 PRO D 306 2 -1.25 CISPEP 5 MET E 305 PRO E 306 2 -1.34 CRYST1 P 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1 MODEL 2 MODEL 3 MODEL 4 MODEL 5 MODEL 6 MODEL 7 MODEL 8 MODEL 9 MODEL 10 MODEL 11 MODEL 12 MODEL 13 MODEL 14 MODEL 15